Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert El-Maraghi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Case Reports in Oncology|September 7, 2018
Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung AdenocarcinomaRouslan Kotchetkov, Robert El-Maraghi, Leena Narsinghani
Advances in Therapy|April 18, 2016
nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT TrialMustapha Tehfe, Scot Dowden, Hagen Kennecke, et al.
British Journal of Cancer|June 29, 2016
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancerE Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, et al.
The New England Journal of Medicine|December 5, 2018
Apixaban to Prevent Venous Thromboembolism in Patients with CancerMarc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Case Reports in Oncology|September 7, 2018
Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung AdenocarcinomaRouslan Kotchetkov, Robert El-Maraghi, Leena Narsinghani
Advances in Therapy|April 18, 2016
nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT TrialMustapha Tehfe, Scot Dowden, Hagen Kennecke, et al.
British Journal of Cancer|June 29, 2016
Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancerE Gabriela Chiorean, Daniel D Von Hoff, Josep Tabernero, et al.
The New England Journal of Medicine|December 5, 2018
Apixaban to Prevent Venous Thromboembolism in Patients with CancerMarc Carrier, Karim Abou-Nassar, Ranjeeta Mallick, et al.
Pageof 1